Thu 05/12/2022 11:43 AM
Share this article:
French manufacturer of natural health products Arkopharma is preparing a sale, sources told Reorg. Rothschild is advising the owner Montagu Private Equity and the company is being marketed off EBITDA of about €45 million, sources said.

Direct lenders are monitoring the upcoming sale and expect the debt to be financed with a unitranche with leverage levels expected between 4.5x and 5x, sources said, noting that the company is cash generative.

However, some sources mentioned
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2022 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!